MISSISSAUGA, Ontario, March 12, 2026 (GLOBE NEWSWIRE)-- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the fourth quarter and full year ended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results